Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 ...
Cleansing Notice
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Imricor Medical Systems, Inc. has issued a cleansing notice regarding the issuance of new shares under the Corporations Act. The company issued a specific number of Class A Common Stock upon the exercise of existing warrants. Imricor confirms compliance with relevant sections of the Corporations Act and provides assurance that no critical information has been excluded from disclosure. This notice serves to inform investors about the new securities and their equal ranking with existing shares.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Application for quotation of securities - IMR
- S&P DJI Announces September 2026 Quarterly Rebalance
- FDA Accepts Imricor PMA Manufacturing Module
- Release from Voluntary Escrow
- Imricor and Philips Launch Commercial iMR Lab Solution
Later from Imricor Medical Systems
- FDA Completes Review of Third PMA Module
- Notification regarding unquoted securities - IMR
- Notification of cessation of securities - IMR
- Q3 FY26 Results Webinar Notification
- Q3 CY2026 Quarterly Activities Report & Form 10-Q Submission
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems